Adagene(ADAG),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ADAG Adagene

Trading 08-21 14:29:06 EDT

4.00

-0.09

-2.20%

High4.12	Low3.97	Vol43.94K
Open4.11	D1 Closing4.09	Amplitude3.55%
Mkt Cap268.57M	Tradable Cap235.50M	Total Shares67.14M
T/O177.17K	T/O Rate0.07%	Tradable Shares58.88M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"ADAG","market":"US","secType":"STK","nameCN":"Adagene","latestPrice":4,"timestamp":1787336673447,"preClose":4.09,"halted":0,"volume":43940,"delay":0,"changeRate":-0.02200488997555009,"floatShares":58875900,"shares":67143300,"eps":-0.3773,"marketStatus":"Trading","change":-0.09,"latestTime":"08-21 14:29:06 EDT","open":4.11,"high":4.115,"low":3.97,"amount":177173.28616,"amplitude":0.035452,"askPrice":4.01,"askSize":500,"bidPrice":3.99,"bidSize":48,"shortable":3,"etf":0,"ttmEps":-0.3773,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1787342400000},"marketStatusCode":2,"adr":0,"adrRate":1.25,"listingDate":1612846800000,"exchange":"NASDAQ","adjPreClose":4.09,"preHourTrading":{"tag":"盘前","latestPrice":4.01,"preClose":4.09,"latestTime":"08:51 EDT","volume":2,"amount":8.02,"timestamp":1787316667169,"change":-0.08,"changeRate":-0.01956,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":4.09,"preClose":4.09,"latestTime":"19:30 EDT","volume":160,"amount":656.67,"timestamp":1787268601156,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.14132},"requestUrl":"/m/hq/s/ADAG/tweets","defaultTab":"tweets","newsList":[{"id":"2660814072","title":"Adagene Management Attends Morgan Stanley Global Healthcare Conference Fireside Chat","url":"https://stock-news.laohu8.com/highlight/detail?id=2660814072","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660814072?lang=en_us&edition=fundamental","pubTime":"2026-08-20 20:05","pubTimestamp":1787227501,"startTime":"0","endTime":"0","summary":"Adagene management attends Morgan Stanley global healthcare conference fireside chatAdagene management will attend three investor conferences in New York in September 2026.Meetings are scheduled at th","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nNDL5qffS9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","SG9999014013.SGD","NDAQ","IE00BQXX3F31.USD","IE00B64PRP62.GBP","IE00BQXX3C00.GBP","BCDF","ADAG","LU2210150020.SGD","SG9999014021.USD","IE00BKPKM429.USD","BK4139","IE00B3QW5Z07.USD","LU2210149790.SGD","IE00BN0W2W23.USD","SG9999014005.SGD","IE00BQXX3D17.EUR","LU2095319765.USD","IE00BN0W2T93.GBP","IE00BN0W2V16.EUR","BK4112","SG9999014039.USD","IE00BGHQF748.EUR","LU0314104364.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660284362","title":"Adagene to Participate in Three Upcoming Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2660284362","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660284362?lang=en_us&edition=fundamental","pubTime":"2026-08-20 20:00","pubTimestamp":1787227200,"startTime":"0","endTime":"0","summary":"SAN DIEGO and SUZHOU, China, Aug.  20, 2026 (GLOBE NEWSWIRE) -- Adagene Inc. (Nasdaq: ADAG) a platform-driven, clinical-stage biotechnology company transforming the discovery and development of novel ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/20/3348306/0/en/adagene-to-participate-in-three-upcoming-investor-conferences.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0266512127.USD","BK4213","BK4139","LU0456854461.SGD","MSS","BK4113","CRC","ADAG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660977404","title":"Adagene Director Cuong Do Reports Purchase of ADS Worth $7,500","url":"https://stock-news.laohu8.com/highlight/detail?id=2660977404","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660977404?lang=en_us&edition=fundamental","pubTime":"2026-08-19 06:11","pubTimestamp":1787091117,"startTime":"0","endTime":"0","summary":"Adagene director Cuong Do reports purchase of ADS worth $7,500Adagene director Do Cuong V bought 2,000 American Depositary Shares at USD 3.75 each.Direct holdings rose to 2,000 ADS following the purch","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nNDL2Sd6B8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Adagene Director Cuong Do Reports Purchase of ADS Worth $7,500","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADAG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660436627","title":"Analysts Offer Insights on Healthcare Companies: Adagene (ADAG) and Natera (NTRA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2660436627","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660436627?lang=en_us&edition=fundamental","pubTime":"2026-08-17 23:20","pubTimestamp":1786980007,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Adagene (ADAG) and Natera (NTRA). Adagene (ADAG) M...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-adagene-adag-and-natera-ntra-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-adagene-adag-and-natera-ntra-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0053671581.USD","BK4588","LU2324357040.USD","LU2065170008.USD","XLV","BK4581","XBI","HELX","LABU","LU2065169927.USD","NTRA","ADAG","GNOM","LU2065171311.SGD","BK4137","LU0012050646.USD","LU2264538146.SGD","LU1064131342.USD","LU0029874061.USD","LU0963586101.USD","BK4139","LU0106261612.USD","LU2065731478.USD","HCSG","LU0345770308.USD","BK4585","LU0128526141.USD","LU2065171402.SGD","LU1988902786.USD","LU0345770993.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659315159","title":"Analysts Offer Insights on Healthcare Companies: Monte Rosa Therapeutics (GLUE), Mineralys Therapeutics, Inc. (MLYS) and Adagene (ADAG)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659315159","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659315159?lang=en_us&edition=fundamental","pubTime":"2026-08-13 19:10","pubTimestamp":1786619422,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Monte Rosa Therapeutics (GLUE), Mineralys Therapeuti...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-monte-rosa-therapeutics-glue-mineralys-therapeutics-inc-mlys-and-adagene-adag-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-monte-rosa-therapeutics-glue-mineralys-therapeutics-inc-mlys-and-adagene-adag-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4137","ADAG","LU0128526141.USD","BK4539","MLYS","LU0029874061.USD","BK4588","LABU","XLV","XBI","HCSG","BK4581","BK4139","GLUE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659990126","title":"Wall Street Analysts Are Bullish on Top Healthcare Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2659990126","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659990126?lang=en_us&edition=fundamental","pubTime":"2026-08-13 01:20","pubTimestamp":1786555206,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Orchestra BioMed Holdings (OBIO) and Adagene (ADAG) ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-297?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-297?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ADAG","BK4139","BK4082","OBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658974198","title":"Adagene FY26 H1 Net Loss Widens to US$ 16.4 Million; Revenue Turns to US$ 1.6 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2658974198","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658974198?lang=en_us&edition=fundamental","pubTime":"2026-08-12 19:38","pubTimestamp":1786534726,"startTime":"0","endTime":"0","summary":"Adagene FY26 H1 net loss widens to US$ 16.4 million; revenue turns to US$ 1.6 millionAdagene posted a GAAP net loss attributable to shareholders of US$16.4 million for the six months ended June 30, 20","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nNDLCq3yn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IE00BKPKM429.USD","LU2095319765.USD","IE00B64PRP62.GBP","IE00BN0W2T93.GBP","LU2210149790.SGD","SG9999014013.SGD","LU0314104364.USD","IE00BN0W2V16.EUR","SG9999014021.USD","IE00BGHQF748.EUR","IE00BN0W2W23.USD","IE00B3QW5Z07.USD","SG9999014039.USD","LU2210150020.SGD","ADAG","BK4112","SG9999014005.SGD","BCDF","BK4585","NDAQ","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658097467","title":"Adagene H1 Adj. EPS $(0.20) Misses $(0.10) Estimate, Sales $1.620M","url":"https://stock-news.laohu8.com/highlight/detail?id=2658097467","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658097467?lang=en_us&edition=fundamental","pubTime":"2026-08-12 19:33","pubTimestamp":1786534408,"startTime":"0","endTime":"0","summary":"Adagene (NASDAQ:ADAG) reported quarterly losses of $(0.20) per share which missed the analyst consensus estimate of $(0.10) by 100 percent. This is a 5.26 percent decrease over losses of $(0.19) per share from the same","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/61137629/adagene-h1-adj-eps-0-20-misses-0-10-estimate-sales-1-620m","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADAG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658749839","title":"Press Release: Adagene Reports Six Months 2026 Financial Results and Provides Corporate Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2658749839","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658749839?lang=en_us&edition=fundamental","pubTime":"2026-08-12 19:30","pubTimestamp":1786534200,"startTime":"0","endTime":"0","summary":"patients that have been treated with a muzastotug dose of either 10 mg/kg. -- In the combined 10 mg/kg cohorts, muzastotug achieved an overall","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADAG","BK4211","ORR","BK4006","BK4232","R","PFS","BK4195","HCC","COAL","BK4022","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657015644","title":"Adagene Inc. Expected to Post a Loss of 10 Cents a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2657015644","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657015644?lang=en_us&edition=fundamental","pubTime":"2026-08-07 22:42","pubTimestamp":1786113725,"startTime":"0","endTime":"0","summary":"Adagene Inc. <ADAG.OQ> expected to post a loss of10cents a share - Earnings PreviewAdagene Inc.ADAG.OQ,ADAG.Ois expected to  report resultson August 10  for the period ending March 31 2026LSEG's mean analyst estimate for Adagene Inc. is for a loss of 10 cents per share.The current average analyst rating on the shares is \"buy\" and the breakdown of recommendations is 6 \"strong buy\" or \"buy,\" 1 \"hold\" and no \"sell\" or \"strong sell.\"The mean earnings estimate of analysts was unchanged in the last three months. Wall Street's median 12-month price target for Adagene Inc. is $9.00, about 117.4% above its last closing price of $4.14This summary was machine generated August 7 at 14:42 GMT.  All figures in US dollars unless otherwise stated.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nL8N4441PP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADAG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657669086","title":"Adagene CEO Peter Luo Buys 23,245 ADS Worth $84,763.97","url":"https://stock-news.laohu8.com/highlight/detail?id=2657669086","media":"Reuters","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657669086?lang=en_us&edition=fundamental","pubTime":"2026-08-07 06:34","pubTimestamp":1786055645,"startTime":"0","endTime":"0","summary":"Adagene CEO Peter Luo buys 23,245 ADS worth $84,763.97Adagene CEO Peter Luo bought 23,245 ADS at about USD 3.65 per share.Directly held ADS position rose to 68,245 shares following the purchases.Also ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nNDL2pKLSR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Adagene CEO Peter Luo Buys 23,245 ADS Worth $84,763.97","news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADAG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651170928","title":"Wall Street Analysts Are Bullish on Top Healthcare Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2651170928","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651170928?lang=en_us&edition=fundamental","pubTime":"2026-07-14 19:10","pubTimestamp":1784027409,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Adagene (ADAG), ANI Pharmaceuticals (ANIP) and Erasc...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-251?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-251?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","LU0566484027.USD","BK4007","ANIP","LU1559883803.SGD","ADAG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649603823","title":"Adagene Posts Investor Presentation Highlighting Adg126 Masked Anti-ctla-4 Program in MSS Colorectal Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2649603823","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649603823?lang=en_us&edition=fundamental","pubTime":"2026-07-07 10:06","pubTimestamp":1783390001,"startTime":"0","endTime":"0","summary":"Adagene posts investor presentation highlighting ADG126 masked anti-CTLA-4 program in MSS colorectal cancerAdagene outlined ADG126 (muzastotug), a masked anti-CTLA-4 with FDA Fast Track designation, p","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260707:nNDL76CKJJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4550","INCY","BK4585","IDNA","BK4532","ADAG","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634847211","title":"Adagene joins Stifel Annual Virtual Oncology Event for fireside chat, investor meetings","url":"https://stock-news.laohu8.com/highlight/detail?id=2634847211","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634847211?lang=en_us&edition=fundamental","pubTime":"2026-05-12 20:31","pubTimestamp":1778589100,"startTime":"0","endTime":"0","summary":"Adagene management scheduled to join Stifel Annual Virtual Oncology Event May 19-20, 2026, including a fireside chat at 2:30 p.m. ET on May 19.One-on-one investor meetings planned at Jefferies Global Healthcare Conference in New York on June 3-4, 2026.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nNDL2dfB5D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014039.USD","SG9999014021.USD","BK4588","LU2095319765.USD","LU2210150020.SGD","IE00BN0W2W23.USD","ADAG","IE00BKPKM429.USD","NDAQ","SG9999014013.SGD","IE00BGHQF748.EUR","IE00BN0W2T93.GBP","LU0314104364.USD","IE00B3QW5Z07.USD","SG9999014005.SGD","BK4112","BK4139","LU2210149790.SGD","IE00BN0W2V16.EUR","IE00B64PRP62.GBP","SF","BK4127","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634821173","title":"Adagene to Participate in Two Upcoming Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2634821173","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634821173?lang=en_us&edition=fundamental","pubTime":"2026-05-12 20:30","pubTimestamp":1778589000,"startTime":"0","endTime":"0","summary":"SAN DIEGOandSUZHOU, China, May  12, 2026  (GLOBE NEWSWIRE) -- Adagene Inc. (“Adagene or the Company”) (Nasdaq: ADAG), a company transforming the discovery and development of novel antibody-based thera","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/12/3292842/0/en/Adagene-to-Participate-in-Two-Upcoming-Investor-Conferences.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0266512127.USD","ADAG","MSS","CRC","BK4113","BK4139","BK4213","LU0456854461.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632867907","title":"Analysts Offer Insights on Healthcare Companies: Adagene (ADAG) and Summit Therapeutics (SMMT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2632867907","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632867907?lang=en_us&edition=fundamental","pubTime":"2026-05-03 01:20","pubTimestamp":1777742407,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Adagene (ADAG) and Summit Therapeutics (SMMT) with b...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-adagene-adag-and-summit-therapeutics-smmt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-adagene-adag-and-summit-therapeutics-smmt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","LU0128526141.USD","LU2488822045.USD","LABU","XBI","BK4585","BK4588","HCSG","LU0029874061.USD","ADAG","BK4139","BK4137","XLV","SMMT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630398107","title":"Analyst Initiates Buy on Muza Developer, Citing Promising MSS CRC Data, Clear Registrational Path, and Broader Expansion Upside Despite Cash Constraints","url":"https://stock-news.laohu8.com/highlight/detail?id=2630398107","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630398107?lang=en_us&edition=fundamental","pubTime":"2026-04-27 18:55","pubTimestamp":1777287356,"startTime":"0","endTime":"0","summary":"Analyst Charles Zhu of LifeSci Capital maintained a Buy rating on Adagene, with a price target of $8.00. Charles Zhu has given his Buy rating due t...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/analyst-initiates-buy-on-muza-developer-citing-promising-mss-crc-data-clear-registrational-path-and-broader-expansion-upside-despite-cash-constraints-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/analyst-initiates-buy-on-muza-developer-citing-promising-mss-crc-data-clear-registrational-path-and-broader-expansion-upside-despite-cash-constraints-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0266512127.USD","ADAG","MSS","CRC","BK4113","BK4139","BK4213","LU0456854461.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628782691","title":"Adagene Showcases Promising Muzastotug Triplet Data at AACR 2026 for Liver and Colorectal Cancers","url":"https://stock-news.laohu8.com/highlight/detail?id=2628782691","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628782691?lang=en_us&edition=fundamental","pubTime":"2026-04-18 04:53","pubTimestamp":1776459208,"startTime":"0","endTime":"0","summary":"Adagene ( ($ADAG) ) has shared an update. On April 17, 2026, Adagene presented new clinical data at the AACR 2026 meeting from two ongoing Phase 1b...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/adagene-showcases-promising-muzastotug-triplet-data-at-aacr-2026-for-liver-and-colorectal-cancers?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/adagene-showcases-promising-muzastotug-triplet-data-at-aacr-2026-for-liver-and-colorectal-cancers?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ADAG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628848727","title":"Adagene presents data from two Phase 1b/2 studies of muzastotug at AACR","url":"https://stock-news.laohu8.com/highlight/detail?id=2628848727","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628848727?lang=en_us&edition=fundamental","pubTime":"2026-04-18 04:15","pubTimestamp":1776456950,"startTime":"0","endTime":"0","summary":"Adagene (ADAG) presented new data from two ongoing Phase 1b/2 studies of muzastotug in triple combination regimens at the American Association of C...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/adagene-presents-data-from-two-phase-1b-2-studies-of-muzastotug-at-aacr-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/adagene-presents-data-from-two-phase-1b-2-studies-of-muzastotug-at-aacr-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ADAG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628781277","title":"Adagene Presents Two Posters at AACR 2026 with New Data Highlighting Muzastotug’s Potential as a Backbone Combination Therapy for Multiple Tumor Types","url":"https://stock-news.laohu8.com/highlight/detail?id=2628781277","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628781277?lang=en_us&edition=fundamental","pubTime":"2026-04-18 04:01","pubTimestamp":1776456060,"startTime":"0","endTime":"0","summary":"Triple combination of muzastotug + atezolizumab + bevacizumab resulted in much higher overall response rates (ORR) compared to the atezolizumab + bevacizumab control arm (66.7% vs. 32.5%, respectively","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/17/3276474/0/en/Adagene-Presents-Two-Posters-at-AACR-2026-with-New-Data-Highlighting-Muzastotug-s-Potential-as-a-Backbone-Combination-Therapy-for-Multiple-Tumor-Types.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4571","BK4006","LU0456854461.SGD","BK4600","BK4563","LU0269904917.USD","BK4535","BTFL","LU0359202008.SGD","LU0359201612.USD","BK4113","BK4565","BK4108","KEEX","SG9999011746.SGD","LU0266512127.USD","LU0456842615.SGD","IE00BYQNZ168.SGD","BK4526","01698","BK4595","BK4139","BK4023","BK4552","ADAG","IE00B12V2V27.USD","LU0828238088.HKD","LU0509642566.USD","BK4548","LU1023057109.AUD","LU2039709279.SGD","BK4213","BK4509","IE00BYTNYN87.SGD","BK4531"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.0995},{"period":"1month","weight":0.1114},{"period":"3month","weight":0.0907},{"period":"6month","weight":0.3025},{"period":"1year","weight":0.9758},{"period":"ytd","weight":1.164}],"compareEarnings":[{"period":"1week","weight":-0.0196},{"period":"1month","weight":0.0191},{"period":"3month","weight":0.0227},{"period":"6month","weight":0.1061},{"period":"1year","weight":0.1951},{"period":"ytd","weight":0.1183}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Adagene Inc. is a platform-driven, clinical-stage biopharmaceutical company committed to transforming the discovery and development of novel antibody-based cancer immunotherapies. Their platform is designed to generate therapeutic antibody candidates with unique functional epitopes and species cross-reactivity. These features enable their novel drug discovery strategy to advance from lead identification through vigorous preclinical modeling to biomarker-guided mono- and combination immunotherapy development in clinical settings. They have pioneered a dynamic interface design to harness the conformational diversity of antibodies, which enlarges epitope sampling of a given drug target for differentiated therapeutic antibody development. Their platform is designed to enable the rapid development of precision immunotherapy candidates, through the identification of predictive biomarkers for patient stratification and preselection.","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.330237},{"month":2,"riseRate":0.4,"avgChangeRate":-0.074707},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.132812},{"month":4,"riseRate":0.166667,"avgChangeRate":-0.082401},{"month":5,"riseRate":0.666667,"avgChangeRate":0.056675},{"month":6,"riseRate":0.666667,"avgChangeRate":-0.004737},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.062128},{"month":8,"riseRate":0.666667,"avgChangeRate":0.027284},{"month":9,"riseRate":0.2,"avgChangeRate":-0.076447},{"month":10,"riseRate":0.2,"avgChangeRate":-0.090108},{"month":11,"riseRate":0.6,"avgChangeRate":0.034268},{"month":12,"riseRate":0.4,"avgChangeRate":0.020923}],"exchange":"NASDAQ","name":"Adagene","nameEN":"Adagene","securityTypeName":"DR","adrRate":"1:1"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Adagene(ADAG),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Adagene(ADAG) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Adagene,ADAG,Adagene股票,Adagene股票老虎,Adagene股票老虎国际,Adagene行情,Adagene股票行情,Adagene股价,Adagene股市,Adagene股票价格,Adagene股票交易,Adagene股票购买,Adagene股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Adagene(ADAG),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Adagene(ADAG) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}